Please login to the form below

Not currently logged in
Email:
Password:

Evotec enters new alliance with Genentech

Evotec and Genentech have formed a new integrated drug discovery alliance to support research into novel small molecule therapeutics

Evotec has announced today that it has formed a new alliance with Genentech (owned by Roche) to support Genentech's research to discover novel small molecule therapeutics.

Said Dr Werner Lanthaler, Evotec's CEO: "We are proud that Genentech, one of the premier biopharmaceutical companies worldwide, has selected Evotec's scientists and innovative drug discovery platform to support its research efforts. We look forward to working closely with Genentech's scientists and achieving success together."

The collaboration includes assay development and high throughput screening, medicinal chemistry and structural biology. Terms for the collaboration have not been disclosed.

Roche (one of several pharma companies working jointly with Evotec to develop its pipeline of products) already has several collaborative research areas in place, including one for product development in treatment-resistant depression and another to jointly discover and develop compounds against a target for CNS diseases and other indications.

Evotec is due to report its financial/performance results for the first quarter of 2010 on Wednesday May 12.

10th May 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...
InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...

Infographics